Jupiter Neurosciences Inc.

Jupiter Neurosciences Inc. is a United States-based biopharmaceutical company focused on the research and development of therapies for neurological diseases and disorders. The company is dedicated to addressing unmet medical needs in areas such as rare diseases and conditions affecting the central nervous system. Through scientific innovation and clinical research, Jupiter Neurosciences aims to develop novel treatments that can improve the lives of patients suffering from debilitating neurological conditions. Their pipeline includes programs targeting specific pathways involved in neurological dysfunction, with the goal of providing effective therapeutic solutions. The company operates within the biotechnology sector, contributing to advancements in neurological medicine and offering potential benefits to individuals and families affected by these challenging disorders. Jupiter Neurosciences is traded on the NASDAQ exchange under the ticker symbol JUNS.